1657125290.90352517s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +gXrf_v4Th9E9WaXvBiC.BvoAO3tm7Q6A#ds004194/sub-p03/ses-nyuecog01/ieeg/sub-p03_ses-nyuecog01_task-soc_acq-clinical_run-01_channels.tsv
1657125293.14518338s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +TspqFtIzEcg0JEP52FrppzMEqLJAb2fi#ds004194/sub-p03/ses-nyuecog01/ieeg/sub-p03_ses-nyuecog01_task-soc_acq-clinical_run-02_channels.tsv
1657125295.61824393s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +qGNPLDzwPHkL5_G.moxXk8W.W2izeLiq#ds004194/sub-p03/ses-nyuecog01/ieeg/sub-p03_ses-nyuecog01_task-soc_acq-clinical_run-03_channels.tsv
1657125297.701904921s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +uaY4cuMNfGBUcuCK1U0IOouWV5Xk63un#ds004194/sub-p03/ses-nyuecog01/ieeg/sub-p03_ses-nyuecog01_task-soc_acq-clinical_run-04_channels.tsv
1657125299.895424345s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +fZnv3.nNTPLYomrCfDh_0xIH1hLTSCTR#ds004194/sub-p03/ses-nyuecog01/ieeg/sub-p03_ses-nyuecog01_task-soc_acq-clinical_run-05_channels.tsv
1657125301.949948589s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +uFsAOMO5.DuGZYxaWkcHucq_ll0a6E5a#ds004194/sub-p03/ses-nyuecog01/ieeg/sub-p03_ses-nyuecog01_task-soc_acq-clinical_run-06_channels.tsv
1657125304.146540439s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +uHNYiaY3cO7_IzWCO2fn_oqXZBycWdu5#ds004194/sub-p03/ses-nyuecog01/ieeg/sub-p03_ses-nyuecog01_task-soc_acq-clinical_run-07_channels.tsv
1657125306.24104057s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +VRzI7TEWIRwAHsyp3VWL5WvrWhNwhm.p#ds004194/sub-p03/ses-nyuecog01/ieeg/sub-p03_ses-nyuecog01_task-soc_acq-clinical_run-08_channels.tsv
1657125308.2973047s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +hCdpb4gMq9edGIMNxbkHw_tIECiz5qD4#ds004194/sub-p03/ses-nyuecog01/ieeg/sub-p03_ses-nyuecog01_task-soc_acq-clinical_run-09_channels.tsv
1657125310.317278669s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +kEBgl8s750bnxt6XnOyn4oc9xldfispT#ds004194/sub-p03/ses-nyuecog01/ieeg/sub-p03_ses-nyuecog01_task-soc_acq-clinical_run-10_channels.tsv
1657125313.01384085s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +q563RYa5_SWiLNIbNmmFWpSv8WVDRqvR#ds004194/sub-p03/ses-nyuecog01/ieeg/sub-p03_ses-nyuecog01_task-soc_acq-clinical_run-11_channels.tsv
1657125315.087947256s 51d08fb4-c58a-4fd7-a171-e5ff8226ca2f:V +GhvkXNS3nY06Iz6wPvIUBgDqT5TQnBfI#ds004194/sub-p03/ses-nyuecog01/ieeg/sub-p03_ses-nyuecog01_task-soc_acq-clinical_run-12_channels.tsv
